Influence of Concurrent and Adjuvant Temozolomide on Health-Related Quality of Life of Patients with Grade III Gliomas: A Secondary Analysis of a Randomized Clinical Trial (KNOG-1101 Study)

PURPOSE: The KNOG-1101 study showed improved 2-year progression-free survival (PFS) with temozolomide during and after radio-therapy compared to radiotherapy alone for patients with anaplastic gliomas. This trial investigates the effect of concurrent and adjuvant temozolomide on health-related quali...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahn, Grace S., Hwang, Kihwan, Kim, Tae Min, Park, Chul Kee, Chang, Jong Hee, Jung, Tae-Young, Kim, Jin Hee, Nam, Do-Hyun, Kim, Se-Hyuk, Yoo, Heon, Hong, Yong-Kil, Kim, Eun-Young, Lee, Dong-Eun, Joo, Jungnam, Kim, Yu Jung, Choe, Gheeyoung, Choi, Byung Se, Kang, Seok-Gu, Kim, Jeong Hoon, Kim, Chae-Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016307/
https://www.ncbi.nlm.nih.gov/pubmed/34237210
http://dx.doi.org/10.4143/crt.2021.393

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016307/
https://www.ncbi.nlm.nih.gov/pubmed/34237210
http://dx.doi.org/10.4143/crt.2021.393

Ejemplares similares